Venture Capital Deals and Investments
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Venture Capital Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
The EVERY Company Secures $55M Series D Funding
Series DVenture Capital

The EVERY Company Secures $55M Series D Funding

•November 4, 2025
•Nov 4, 2025
0

Participants

New Agrarian

New Agrarian

investor

McWin Capital Partners

McWin Capital Partners

investor

SOSV

SOSV

investor

Main Sequence

Main Sequence

investor

Bloom8

Bloom8

investor

Minerva Foods

Minerva Foods

investor

Why It Matters

The infusion of $55 million accelerates commercialization of sustainable, animal‑free egg proteins, offering food producers a low‑environmental‑impact alternative and reshaping supply chains in the protein market.

Deal Summary

The EVERY Company, a precision‑fermentation biotech firm, announced a $55 million Series D round to expand its egg‑protein ingredient platform. The financing was led by McWin Capital Partners with participation from Main Sequence, Bloom8, TO.VC, Minerva Foods, Grosvenor Food & Ag, New Agrarian, SOSV and others.

0

Comments

Want to join the conversation?

Loading comments...